Page 59 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

Natural history of recurrent pleomorphic adenoma
22. Carew JF, Spiro RH, Singh B, Shah JP. Treatment of recurrent pleomorphic adenomas of the parotid gland. Otolaryngol - Head Neck Surg. 1999;121(5):539-542. doi:10.1016/S0194-5998(99)70053-7
23. Suh M, Hah J, Kwon S, et al. Clinical manifestations of recurrent parotid pleomorphic adenoma. Clin Exp Otorhinolaryngol. 2009;2(4):193-197. doi:10.3342/ceo.2009.2.4.193
24. Nøhr A, Andreasen S, Therkildsen MH, Homoe P. Stationary facial nerve paresis after surgery for recurrent parotid pleomorphic adenoma: a follow-up study of 219 cases in Denmark in the period 1985-2012. Eur Arch Otorhinolaryngol. 2016;273(10):3313-3319. doi:10.1007/s00405-016-3921-9
25. Malard O, Wagner R, Joubert M, et al. prognostic factors for secondary recurrence of pleomorphic adenoma: a 20-year, retrospective study. J Laryngol Otol. 2013;127(9):902-907. doi:10.1017/ S0022215113001801
26. Leonetti J, Marzo S, Petruzzelli G, Herr B. Recurrent pleomorphic adenoma of the parotid gland. Otolaryngol Head Neck Surg. 2005;133(3):319-322. doi:10.1016/j.otohns.2005.04.008
27. Abu-Ghanem Y, Mizrachi A, Popovtzer A, Abu-Ghanem N, Feinmesser R. Recurrent pleomorphic adenoma of the parotid gland: Institutional experience and review of the literature. J Surg Oncol. 2016;114(6):714-718. doi:10.1002/jso.24392
28. Liu H, Wen W, Huang H, et al. Recurrent Pleomorphic Adenoma of the Parotid Gland: Intraoperative Facial Nerve Monitoring during Parotidectomy. Otolaryngol Head Neck Surg. 2014;151(1):87-91. doi:10.1177/0194599814528098
29. McGurk M, Renehan A, Gleave EN, Hancock BD. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas. Br J Surg. 1996;83(12):1747-1749.
30. Bradley P. The recurrent pleomorphic adenoma conundrum. Curr Opin Otolaryngol Head Neck Surg. 2018;26(2):134-141. doi:10.1097/MOO.0000000000000435.
31. Gunn A, Parrot NR. Parotid tumours: a review of parotid tumour surgery in the Northern Regional Health Authority of the United Kingdom 1978-1982. Br J Surg. 1988;75(11):1144-1146.
32. Di Palma S, Guzzo M. Malignant myoepithelioma of salivary glands: Clinicopathological features of ten cases. Virchows Arch - A Pathol Anat Histopathol. 1993;423(5):389-396.
33. Soares AB, Demasi AP, Altemani A, de Araujo VC. Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma. Histopathology. 2011;58(3):377- 382. doi:10.1111/j.1365-2559.2011.03758.x
34. Xie S, Wang K, Xu H, et al. PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients. Med. 2015;94(34):e1237. doi:10.1097/MD.0000000000001237
35. Foresta E, Torroni A, Di Nardo F, et al. Pleomorphic adenoma and benign parotid tumors: extracapsular dissection vs superficial parotidectomy--review of literature and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2014;117(6):663-676. doi:10.1016/j.oooo.2014.02.026
36. Albergotti W, Nguyen S, Zenk J, Gillespie M. Extracapsular dissection for benign parotid tumors: a meta-analysis. Laryngoscope. 2012;122(9):1954-1960. doi:10.1002/lary.23396
37. Schneider A, Lubin J, Ron E, et al. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiat Res . 1998;149(6):625- 630.
38. Mc Loughlin L, Gillanders S, Smith S, Young O. The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review. Eur Arch Otorhinolaryngol. 2019;276:283-295. doi:10.1007/s00405-018-5205-z
39. Witt RL, Eisele DW, Morton RP, Nicolai P, Poorten V V, Zbaren P. Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope. 2015;125(4):888-893. doi:10.1002/lary.24964
40. Naunheim M, Wu X, Ryan WR, Wang SJ, Heaton CM. Volumetric Growth Rate of Recurrent Pleomorphic Adenoma. Ann Otol Rhinol Laryngol. 2017;126(7):544-547. doi:10.1177/0003489417708794
3
57